SCHEMBL73961

SCHEMBL73961

c1cc(Nc2ccon2)cc(-c2cnc3ccccn23)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IRAK4 Q9NWZ3 2/20 0.52
CDK2 P24941 3/20 0.49
CDK1 P06493 1/20 0.48
CDK4 P11802 1/20 0.48
MIF P14174 1/20 0.47
PKM P14618 2/20 0.46
FLT3 P36888 1/20 0.44
KDR P35968 7/20 0.43
FGFR3 P22607 6/20 0.43
DYRK1A Q13627 2/20 0.43
DYRK3 O43781 1/20 0.43
CCNT1 O60563 1/20 0.43
CCNA2 P20248 1/20 0.43
CDK9 P50750 1/20 0.43
CDK5 Q00535 1/20 0.43
CDK5R1 Q15078 1/20 0.43
DYRK2 Q92630 1/20 0.43
DYRK1B Q9Y463 1/20 0.43
PIK3CA P42336 2/20 0.41
KIT P10721 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Formic Acid SCHEMBL73159 0.94 IRAK4 (0.47) IRAK4CDK2CDK1CDK4MIF
SCHEMBL72363 0.82 IRAK4 (0.61) IRAK4CDK2CDK1CDK4MIF
SCHEMBL71795 0.80 IRAK4 (0.53) IRAK4CDK2CDK1CDK4MIF
SCHEMBL72956 0.79 CDK2 (0.60) IRAK4CDK2CDK1CDK4MIF
SCHEMBL74774 0.77 CDK2 (0.53) IRAK4CDK2CDK1CDK4MIF
SCHEMBL72789 0.75 FYN (0.63) CDK2KDRFGFR3DYRK1ADYRK3
SCHEMBL73095 0.74 PKM (0.53) IRAK4CDK2CDK1CDK4MIF
SCHEMBL73153 0.74 CDK2 (0.58) IRAK4CDK2CDK1CDK4MIF
SCHEMBL73956 0.74 CDK2 (0.48) IRAK4CDK2CDK1CDK4MIF
SCHEMBL73262 0.74 FGFR3 (0.53) IRAK4CDK2CDK1CDK4MIF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8131527-B1 FGFR pharmacophore compounds ASTEX THERAPEUTICS LTD. (GB) 2012-03-06 US disclosed
US-8131527-B1 FGFR pharmacophore compounds ASTEX THERAPEUTICS LTD. (GB) 2012-03-06 US disclosed
US-8131527-B1 FGFR pharmacophore compounds ASTEX THERAPEUTICS LTD. (GB) 2012-03-06 US disclosed